Released on November 7, 2025 Consolidated Financial Report for the Third Quarter 2025 (Unaudited)(Japan GAAP) AnGes, Inc.
https://www.anges.co.jp/en/
Listings: Growth of the Tokyo Stock Exchange, Code 4563
Head Office: 7-7-15, Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan
(Figures are rounded down to the nearest million yen)
Business Results for the Third Quarter 2025 (From Jan. 1, 2025 to Sep. 30, 2025)
Results of Operations (Percentages indicate changes from the same period of the previous fiscal year)
Revenues
Operating
loss
Ordinary loss
Net loss
Million yen
%
Million yen
%
Million yen
%
Million yen
%
3Q 2025
646
37.0
(3,542)
-
(4,615)
-
(4,688)
-
3Q 2024
471
359.4
(7,042)
-
(7,050)
-
(7,156)
-
*Comprehensive Income 3Q 2025 : (3,711) million yen 3Q 2024 : (6,891) million yen
Net loss per share
Diluted net loss
per share
Yen
Yen
3Q 2025
(13.63)
-
3Q 2024
(32.30)
-
Financial Position
Total assets
Total net assets
Shareholders'
equity ratio
Million yen
Million yen
%
Sep. 30, 2025
6,612
4,172
62.1
Dec. 31, 2024
4,668
2,156
44.0
*Shareholder's equity
Sep. 30, 2025 :
4,105
million yen
Dec. 31, 2024 :
2,052
million yen
Dividend
Dividend per share
1Q
2Q
3Q
4Q
Full-year
Yen
Yen
Yen
Yen
Yen
FY 2024
-
0.00
-
0.00
0.00
FY 2025
-
0.00
-
FY 2025 (Forecast)
0.00
0.00
*Change of dividend forecast from the most recent release: None
Earnings Forecast for the Fiscal Year 2025 (From Jan. 1, 2025 to Dec. 31, 2025)
Revenues | Operating loss | Ordinary loss | Net loss | Net loss per share | |||||
Full-year | Million yen 880 | % 36.7 | Million yen (6,270) | % - | Million yen (6,290) | % - | Million yen (6,320) | % - | Yen (17.82) |
*Change of earnings forecast from the most recent release: None
Notes:
Change of reporting entities (change of condition of significant consolidated subsidiaries)
Accounting procedure peculiar to the quarterly consolidated financial statements
Change of significant accounting and reporting policies for consolidated financial statements
Changes caused by revision of accounting standard : None
Changes in accounting policies other than 1) : None
Changes in accounting estimates : None
Restatement : None
Sep. 30, 2025
386,077,550 shares
Dec. 31, 2024
286,377,550 shares
Sep. 30, 2025
230 shares
Dec. 31, 2024
230 shares
3Q 2025
343,969,168 shares
3Q 2024
221,546,243 shares
Number of shares issued and outstanding (common stock)
Number of shares issued and outstanding (including treasury shares)
: None
: None
Number of treasury shares
Average number of shares issued and outstanding
*Performance forecasts or any other future events contained in this report are based on currently available information which are believed to be reasonable at the time of forecasts. Actual results may differ from the forecasts due to various factors.
**This financial report has been translated from Japanese original which has been prepared in accordance with generally accepted accounting principles in Japan, for reference purposes only. Also some changes are added to this report in order to present in a form more familiar to the readers outside Japan.
AnGes, Inc Consolidated Balance Sheets (In thousands of yen) (Unaudited) | ||
December 31, 2024 | September 30, 2025 | |
Assets | ||
Current assets | ||
Cash and deposits | 1,707,756 | 3,552,298 |
Accounts receivable - trade | 85,235 | 113,597 |
Merchandise | 224,803 | 314,004 |
Raw materials and supplies | 1,204,382 | 1,248,236 |
Advance payments to suppliers | 65,547 | 104,825 |
Prepaid expenses | 69,532 | 107,579 |
Consumption taxes refund receivable | 175,447 | 109,907 |
Other | 9,903 | 16,858 |
Total current assets | 3,542,608 | 5,567,306 |
Non-current assets | ||
Property, plant and equipment | ||
Buildings | 220,509 | 226,009 |
Accumulated depreciation | (141,951) | (147,599) |
Buildings, net | 78,558 | 78,410 |
Tools, furniture and fixtures | 212,358 | 219,691 |
Accumulated depreciation | (116,029) | (147,942) |
Tools, furniture and fixtures, net | 96,328 | 71,749 |
Total property, plant and equipment | 174,887 | 150,160 |
Intangible assets | ||
Software | 9,661 | 8,136 |
Total intangible assets | 9,661 | 8,136 |
Investments and other assets | ||
Investment securities | 441,804 | 402,312 |
Long-term loans receivable | - | 15,000 |
Leasehold and guarantee deposits | 97,672 | 97,447 |
Deferred tax assets | 401,016 | 368,632 |
Other | 948 | 3,276 |
Total investments and other assets | 941,441 | 886,668 |
Total non-current assets | 1,125,990 | 1,044,965 |
Total assets | 4,668,599 | 6,612,271 |
AnGes, Inc Consolidated Balance Sheets (In thousands of yen) (Unaudited) | ||
December 31, 2024 | September 30, 2025 | |
Liabilities | ||
Current liabilities | ||
Accounts payable - trade | 307,944 | 357,590 |
Accounts payable - other | 306,991 | 280,678 |
Accrued expenses | 32,809 | 32,289 |
Provision for business restructuring | 166,182 | 134,098 |
Income taxes payable | 681,828 | 703,694 |
Advances received | 639,500 | 666,035 |
Deposits received | 14,172 | 13,479 |
Lease liabilities | 163,853 | 170,149 |
Total current liabilities | 2,313,283 | 2,358,015 |
Non-current liabilities | ||
Deferred tax liabilities | 25,584 | 16,730 |
Asset retirement obligations | 64,544 | 64,629 |
Lease liabilities | 108,595 | - |
Total non-current liabilities | 198,724 | 81,360 |
Total liabilities | 2,512,007 | 2,439,376 |
Net assets | ||
Shareholders' equity | ||
Share capital | 37,255,887 | 40,138,427 |
Capital surplus | 5,502,588 | 8,385,318 |
Retained earnings | (46,514,594) | (51,203,414) |
Treasury shares | (39) | (39) |
Total shareholders' equity | (3,756,157) | (2,679,708) |
Accumulated other comprehensive income | ||
Valuation difference on available-for-sale securities | 47,444 | 26,936 |
Foreign currency translation adjustment | 5,760,964 | 6,758,484 |
Total accumulated other comprehensive income | 5,808,409 | 6,785,420 |
Share acquisition rights | 104,339 | 67,184 |
Total net assets | 2,156,591 | 4,172,895 |
Total liabilities and net assets | 4,668,599 | 6,612,271 |
2024 | 2025 | |
Business revenues | ||
Net sales of goods | 185,094 | 216,855 |
Net sales of finished goods | 11,623 | - |
Commission income | 199,187 | 412,988 |
Research and development revenues | 75,725 | 16,289 |
Total business revenues | 471,630 | 646,133 |
Business expenses | ||
Cost of sales | 285,341 | 387,307 |
Research and development expenses | 2,928,655 | 2,375,123 |
Selling, general and administrative expenses | 4,299,771 | 1,426,303 |
Total business expenses | 7,513,768 | 4,188,734 |
Operating loss | (7,042,138) | (3,542,600) |
Non-operating income | ||
Interest income | 2,925 | 14,079 |
Foreign exchange gains | 8,629 | - |
Subsidy income | 27,916 | - |
Commission income | 4,190 | 3,862 |
Miscellaneous income | - | 836 |
Total non-operating income | 43,662 | 18,777 |
Non-operating expenses | ||
Share issuance costs | 50,340 | 29,182 |
Loss on investments in investment partnerships | 1,210 | 9,883 |
Foreign exchange losses | - | 1,052,966 |
Total non-operating expenses | 51,550 | 1,092,033 |
Ordinary loss | (7,050,026) | (4,615,855) |
Extraordinary income | ||
Gain on reversal of share acquisition rights | 6,192 | - |
Total extraordinary income | 6,192 | - |
Extraordinary losses | ||
Business structural reform expenses | 21,885 | - |
Total extraordinary losses | 21,885 | - |
Loss before income taxes | (7,065,719) | (4,615,855) |
Income taxes - current | 49,198 | 61,289 |
Income taxes - deferred | 41,906 | 11,675 |
Total income taxes | 91,104 | 72,965 |
Loss | (7,156,824) | (4,688,820) |
Loss attributable to owners of parent | (7,156,824) | (4,688,820) |